CSN Login
Members Online: 12

You are here


Posts: 83
Joined: May 2017

This recent publication showed a cost effective, noninvasive way to determine genetic alterations in metastatic Bladder Cancer. The authors found DNA sequencing from tumor DNA circulating in plasma reveled driver mutations that are often target-able by drugs. http://clincancerres.aacrjournals.org/content/early/2017/08/04/1078-0432.CCR-17-1140

Subscribe to Comments for "ctDNA"